Last reviewed · How we verify

NCT07117994

Radicle Revive 24: A Study of Health and Wellness Products on Hormonal Health and Associated Health Outcomes in Women With Peri-Menopausal Health Issues

Completed NA Last updated 17 December 2025
What this trial tests

NA trial testing Radicle Revive Placebo Control Form 1 in Stress in 500 participants. Completed in 12 November 2025.

Timeline
5 August 2025
Primary endpoint
12 November 2025
12 November 2025

Quick facts

Lead sponsorRadicle Science
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment500
Start date5 August 2025
Primary completion12 November 2025
Estimated completion12 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Radicle Science — full company profile →

Who can join

Adults 40 to 105, female only, with Stress or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Randomized, Double-Blind, Placebo-Controlled, Direct-to-Consumer Trial Assessing the Impact of Health and Wellness Products on Hormonal Health and Associated Health Outcomes in Women with Peri-Menopausal Health Issues

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other Radicle Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07117994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing